Classic Hodgkin lymphoma, nodular sclerosis type

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Classic Hodgkin lymphoma, nodular sclerosis type.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Classic Hodgkin lymphoma, nodular sclerosis type.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Adcetris

(brentuximab vedotin)Orphan drugstandard

Seagen Inc.

CD30-directed Immunoconjugate [EPC]

12.1 Mechanism of Action CD30 is a member of the tumor necrosis factor receptor family and is expressed on the surface of sALCL cells and on Hodgkin R...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Classic Hodgkin lymphoma, nodular sclerosis type.
Search all trials →
Search clinical trials for Classic Hodgkin lymphoma, nodular sclerosis type

Recent News & Research

No recent news articles indexed yet for Classic Hodgkin lymphoma, nodular sclerosis type.
Search PubMed for Classic Hodgkin lymphoma, nodular sclerosis type

Browse all Classic Hodgkin lymphoma, nodular sclerosis type news →

Specialist Network

Top 6 by expertise

View all Classic Hodgkin lymphoma, nodular sclerosis type specialists →

Quick Actions